Psittimune® Avian Polyomavirus Vaccine (APV)
The Only Vaccine for Avian Polyomavirus
Product Description:
Psittimune® APV is a patented avian polyomavirus containing an antigenic isolate of avian polyomavirus. A killed vaccine, Psittimune® APV vaccine aids in the prevention of avian polyomavirus infection prior to virus exposure and is the only federally licensed product of its kind. Vaccination of young, healthy psittacine birds is recommended, and young birds should initially be vaccinated at 5 weeks (35 days) of age. To complete primary immunization, a second dose must be given two to three weeks following initial vaccination. Annual revaccination is recommended and susceptible breeders should be vaccinated prior to laying season.
Key Benefits:
-
The only federally licensed vaccine for avian polyomavirus on the market
-
Successfully prevents infection and death from avian polyomavirus in psittacine birds
For Veterinary Professionals:
Are you a veterinary professional interested in purchase?
Psittimune® APV is available through your veterinarian or by contacting Creative Science.
Directions for Vaccine Administration:
Vaccinate healthy birds with the appropriate size dose (0.5ml for birds weighing 200 gm or greater when adults, 0.25ml for birds weighing less than 200 grams when adults).
Vaccine should be administered subcutaneously with a 23 to 26 gauge needle to one side of the caudal end of the breast avoiding the muscle and the keel. Care should be taken not to inject the vaccine into muscle tissue or internal organs or intradermally.
Administer the second vaccination on the contralateral side two to three weeks later.
Storage & Precautions:
Store the vaccine at 35-45°F (2-7°C). Do not freeze. Warming the vaccine to 85-90°F before use reduces stress on the bird. It is essential to shake the vaccine before and during use since the vaccine quickly settles. Shake the bottle of vaccine well before removing each dose with a syringe and needle. Use entire contents when first opened.
